In type 2 diabetes, GDF-15 predicts the development of proteinuria in patients with diabetic nephropathy, suggesting that GDF-15 may be a part of an anti-inflammatory response to microvascular damages (18). This evidence concerns the gene GDF15 and diabetic kidney disease.